David Bharucha

David Bharucha

Chief Medical OfficeratMilestone Pharmaceuticals· In proxies 2022–2025

Pay in FY2025+61% from the year before · Milestone Pharmaceuticals stock -14.4% the same year

David Bharucha was paid $1.0M in FY2025 (Dec), up 61%. Milestone Pharmaceuticals stock fell 14.4% that year.

Pay$100 in the stock at the end of FY23 → $121
Pay is from the Summary Compensation Table of each Milestone Pharmaceuticals proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Milestone PharmaceuticalsPublic company · 4 yr
    • Chief Medical Officer2022 – Present · 4 yrStock in role -89%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?